FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:129-131 January 8, 1998 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Cohen, M. PubMed Citation

To the Editor: The Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events (ESSENCE) study (Aug. 14 issue),¹ in which a low-molecular-weight heparin was found to be more effective than unfractionated heparin in reducing the incidence of ischemic events in patients with unstable angina or non–Q-wave myocardial infarction, prompted an editorial questioning the future role of unfractionated heparin in patients with acute coronary disease.² In his editorial, Dr. Armstrong noted that although low-molecular-weight heparin was administered in a weight-adjusted dose, this was not the case with unfractionated heparin. Other differences in the use of the two heparin preparations included . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.